SLU Researchers Enroll Participants in 2-in-1 COVID and Flu Vaccine Clinical Trial
ST. LOUIS – Saint Louis University’s Center for Vaccine Development is participating in a clinical study for an investigational vaccine being developed against influenza and COVID developed by Pfizer, which is funding this research.
While there are licensed vaccines and treatments for both influenza and COVID, the current vaccines have been given as separate shots. This study looks at whether both vaccines can be combined into one shot without affecting the antibody response to either vaccine.
Sarah George, M.D., professor of infectious diseases at SLU School of Medicine and a researcher in SLU’s Vaccine Center. SLU file photo.
Sarah George, M.D., professor of infectious diseases at SLU School of Medicine and a researcher in SLU’s Vaccine Center, will assist in studying whether the combined vaccine induces the body to make antibodies to both influenza and COVID, compared with giving both vaccines separately.
“Since it looks like COVID will be with us for the long haul, just as flu is, it’s important to see if we can combine both vaccines into one shot without compromising immunity of both,” George said. “It’s vital that we continue to work to develop combined vaccines that can protect all of us, especially the vulnerable, from these illnesses.”
The phase 3 clinical trial is being conducted at over 200 sites in the United States, including Saint Louis University. SLU researchers are recruiting around 150 healthy adults 18 through 64 years of age who have not had a flu or COVID vaccine in the past 6 months. Overall, the study will recruit 9,000 volunteers and will last about a year. Each volunteer will have 3 study visits.
To learn more about vaccine research being conducted at Saint Louis University, call 314-977-6333 or email vaccine@slu.edu. For more information on this study, please visit the ClinicalTrials.gov website link here.
Latest Newslink
- SLU Launches William L. Clay, Sr. Institute of Civic Engagement and Economic JusticeThe Clay Institute will provide immersive learning experiences and hands-on training that address the social and economic challenges facing the St. Louis region and the nation. Institute programming will be available to all students with an interest in civic engagement and democratic participation.
- SLU Research Explores Depression's Ripple Effect on DiabetesA study conducted by researchers at Saint Louis University found that patients with depression were more likely to have uncontrolled diabetes over time and that depression contributes to a heightened economic burden to diabetes management.
- SLU/YouGov Poll: Statewide Cell Phone Ban for Missouri Schools Popular with VotersGovernor Mike Kehoe has signed Senate Bill 68 into law, enacting a statewide ban on the use of personal electronic devices, including cell phones, tablets, and smartwatches, throughout the school day in Missouri public and public charter schools.
- SLU Vaccine Center Will Enroll Healthy Volunteers in Yellow Fever Vaccine Clinical TrialSaint Louis University's Center for Vaccine Development will enroll up to 70 adult volunteers in a clinical trial to study the safety elicited by a new investigational vaccine for yellow fever, a potentially deadly disease that is spread by mosquitoes. The research is funded by Sanofi Pasteur.
- Feser Joins Global Jesuit Assembly During First Week as SLU's PresidentAs he began his tenure as Saint Louis University's 34th president, Edward Feser, Ph.D., represented SLU as a delegate at the 2025 Assembly of the International Association of Jesuit Universities (IAJU).
- SLU Partnership with St. Louis Catholic Academy Middle School Education Yields Improved Outcomes One Year OnA partnership between Saint Louis University's School of Education's Herrmann Center for Innovative Catholic Education and St. Louis Catholic Academy has yielded improved test scores and student outcomes in the middle school population after its first year. The SLU School of Education provides resources to St. Louis Catholic Academy's middle school.
